Core Viewpoint - Repay Holdings Corporation (RPAY) operates in the financial technology sector, providing integrated payment processing solutions to businesses, and competes with other fintech companies in the same space [1] Stock Performance - On March 10, 2026, Morgan Stanley set a price target of $3.50 for RPAY, indicating a potential increase of about 18.44% from the stock's price of $2.955 at that time [2] - Currently, RPAY's stock price has risen to $3.08, reflecting a 9.47% increase from its previous value [2] - The stock has fluctuated between $2.80 and $3.08 today, with a market capitalization of approximately $281 million [5][6] - Over the past year, RPAY's stock has seen a high of $6.06 and a low of $2.70 [5] Analyst Ratings - RPAY has received a consensus "Hold" rating from ten research firms, with one analyst suggesting selling, five recommending holding, and four advising buying [3] - The average one-year target price from brokers is approximately $6.41, significantly higher than the current price, indicating potential growth [3] - DA Davidson maintains a "buy" rating with a price target of $10.00, while Morgan Stanley reduced their target from $5.00 to $4.00, giving an "equal weight" rating [4] - Wall Street Zen downgraded their rating from "buy" to "hold," and Weiss Ratings continues to recommend selling [4]

Join Qualtrim, the stock analysis platform I built and use, and join over 13,000 other paying members: https://www.qualtrim.com/ 00:00 Overview 02:00 Oil Goes Above $100 25:30 Anthropic Sues Trump Administration 30:20 Netflix Buys Ben Affleck AI Company 34:43 Fail Of The Week: More CEO's Eat Their "product" -Disclaimer Some of the links below are affiliate links, I can earn money from them at no cost to you. This content is not a solicitation, is not endorsed by M1, and was not reviewed by M1; the opinions ...

Core Viewpoint - Alkermes plc is a biopharmaceutical company focused on innovative medicines for central nervous system disorders and cancer, with a market capitalization of approximately $5.13 billion [1] Financial Performance - Alkermes reported a revenue decline of 10.6% for Q4 2025, totaling $384.55 million compared to the previous year [2] - Despite the revenue decline, Alkermes exceeded the Zacks Consensus Estimate of $379.96 million, resulting in a positive surprise of 1.21% [3] - The company reported earnings per share (EPS) of $0.46 for the quarter, surpassing the consensus estimate of $0.43, marking a 7.8% positive surprise, although down from $1.04 EPS in the same quarter last year [4] Stock Performance - The current stock price of ALKS is $31.04, reflecting a decrease of 7.04% or $2.35, with fluctuations between $30.54 and $32.78 during the trading day [5] - Over the past year, ALKS reached a high of $36.32 and a low of $25.17, with a trading volume of 3,898,927 shares indicating active investor interest [5] Analyst Outlook - Douglas Tsao from H.C. Wainwright set a price target of $43 for Alkermes, indicating a potential upside of 38.53% [2][6]

Group 1 - The author has experience in analyzing the entertainment sector, particularly focusing on gaming as a new area of interest [1] - The latest analysis involved Netflix, which has been exploring potential acquisition opportunities [1] - The content is aimed at both beginners and advanced readers, providing a distinct perspective on market analysis [1] Group 2 - The author operates a YouTube channel called "The Market Monkeys," where stock analyses are shared [1]

Core Viewpoint - Tandem Diabetes Care, Inc. is a prominent player in the insulin pump technology market, showing resilience against competition from major companies like Medtronic and Insulet Corporation [1] Company Performance - RBC Capital maintains an "Outperform" rating for Tandem Diabetes, raising its price target from $25 to $30, reflecting confidence in the company's growth potential [2] - The average twelve-month price target from brokerages is approximately $22.44, slightly below the current stock price of $23.03, indicating a modest increase of 1.90% or $0.43 [3] Analyst Sentiment - Analyst ratings for Tandem Diabetes show mixed sentiment: one "sell," eleven "hold," and five "buy" recommendations [3] - Stifel Nicolaus initiated coverage with a "hold" rating and a target price of $15.00, while Canaccord Genuity reaffirmed a "buy" rating with a price objective of $24.00 [4] Stock Performance - The stock has fluctuated between a low of $22.40 and a high of $23.10 during the day, with a yearly peak of $38.28 and a low of $9.98 [5] - Tandem Diabetes Care has a market capitalization of approximately $1.56 billion and a trading volume of 120,728 shares on the NASDAQ exchange [5]

Core Insights - The article focuses on the cannabis sector, emphasizing technical stock analysis, option strategies, small cap strategies, and emerging markets [1] Group 1 - The author expresses a keen interest in the cannabis industry and its publicly traded stocks [1] - There is an invitation for readers to engage with questions regarding stocks in the cannabis sector [1]

Core Insights - Advanced Micro Devices (AMD) has experienced a significant stock price increase of approximately 46% since the last coverage, indicating strong market performance and investor interest [1]. Financial Performance - The analysis focuses on AMD's Q3'25 results, which are expected to provide insights into the company's financial health and operational efficiency [1]. Investment Perspective - The article aims to share thoughts on why AMD presents a compelling investment opportunity, suggesting potential for continued growth and value creation in the semiconductor industry [1].

Core Insights - Advanced Micro Devices (AMD) has experienced a significant stock price increase of approximately 46% since the last coverage, indicating strong market performance and investor interest [1]. Financial Performance - The analysis focuses on AMD's Q3'25 results, which are expected to provide insights into the company's financial health and operational efficiency [1]. Investment Perspective - The article aims to share thoughts on why AMD presents a compelling investment opportunity, suggesting potential for continued growth and value creation in the semiconductor industry [1].

Product Offering - Meitou Pro offers 100 video analyses per year, providing in-depth stock analysis and market tracking [1] - Meitou Pro features 8 professional analysts and a community of thousands of members for discussion [1] - Meitou Pro shares daily investment perspectives, professional data, and trading summaries [1] - Meitou Pro's video library contains over 200 videos and more than 10,000 investment ideas [1] Content Focus - The platform covers various investment topics, including postmodern cycles, electric vehicle investment, and strategies to outperform Wall Street [1] - The platform also covers topics such as US Treasury bond market, quantitative risk, and popular investment strategies [1] - The platform provides educational content on ETFs, AI investment limitations, and asset allocation [1] - The platform offers option trading tutorials, including basic concepts, practical demonstrations, and strategies for using traditional stocks for options [1] - The platform discusses investment strategies, including how to determine a company's intrinsic value, risk management, and dividend stock investing [1] - The platform explores investment psychology, aiming to help investors make rational decisions and overcome emotional biases [1] - The platform provides industry-specific analysis on sectors like payment, cloud computing, healthcare, streaming, Chinese stocks, cannabis, metaverse, and AI [1] Channels and Contact - Meitou team has other YouTube channels, including "Meitou Kan News" and "Meitou Talks Options" [1] - Business cooperation can be reached via meitouinvesting@gmailcom [1] - The WeChat public account is Meitou_Investing, and the WeChat ID is meitoujiangmeigu [1]

Core Insights - Dow Inc. is identified as an excessively cheap materials stock, with mild revenue declines noted earlier in the year [1] Company Analysis - The analysis highlights Dow Inc.'s position in the materials sector, suggesting potential undervaluation [1] - The focus on revenue trends indicates a cautious outlook on the company's financial performance [1] Analyst Background - The analyst has a Bachelor of Commerce Degree with Distinction, majoring in Finance, and is a member of the Beta Gamma Sigma International Business Honor Society, emphasizing a strong educational background [1] - Core values of excellence, integrity, transparency, and respect are highlighted as essential for long-term success in investment analysis [1]